Skip to search formSkip to main contentSkip to account menu

apicidin

Known as: cyclo(N-O-methyl-tryptophyl-isoleucyl-pipecolinyl-2-amino-8-oxodecanoyl) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Apicidin, as an inhibitor of histone deacetylase, showed a wide range of antiproliferative activity against various… 
2010
2010
BackgroundGranulocytes are important in the pathogenesis of several inflammatory diseases. Apoptosis is pivotal in the resolution… 
Highly Cited
2009
Highly Cited
2009
Fooling enzymes with mock amides: Analogues of apicidin, a cyclic-tetrapeptide inhibitor of histone deacetylase (HDAC), were… 
2008
2008
The cellular susceptibility of cancer cells to histone deacetylase (HDAC) inhibitors is increased by the etopic expression of… 
2007
2007
Some histone deacetylase inhibitors (HDACi) have recently been related to teratogenic effects in rodents. Skeletal defects have… 
2006
2006
Histone deacetylase (HDAC) inhibitors are promising anti-cancer drugs, but these exert differential responses depending on the… 
2004
2004
Apicidin, a histone deacetylase inhibitor, is a novel cyclic tetrapeptide with potent antiproliferative activity against various… 
2003
2003
We previously reported that the activation of p21WAF1/Cip1 transcription by histone deacetylase inhibitor apicidin was mediated… 
Highly Cited
2000
Highly Cited
2000
Apicidin's indole was efficiently converted into a series of N-substituted quinolone derivatives by indole N-alkylation followed…